Culture impact on the transcriptomic programs of primary and iPSC-derived human alveolar type 2 cells.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
10 01 2023
Historique:
received: 31 01 2022
accepted: 21 11 2022
pubmed: 2 12 2022
medline: 12 1 2023
entrez: 1 12 2022
Statut: epublish

Résumé

Dysfunction of alveolar epithelial type 2 cells (AEC2s), the facultative progenitors of lung alveoli, is implicated in pulmonary disease pathogenesis, highlighting the importance of human in vitro models. However, AEC2-like cells in culture have yet to be directly compared to their in vivo counterparts at single-cell resolution. Here, we performed head-to-head comparisons among the transcriptomes of primary (1°) adult human AEC2s, their cultured progeny, and human induced pluripotent stem cell-derived AEC2s (iAEC2s). We found each population occupied a distinct transcriptomic space with cultured AEC2s (1° and iAEC2s) exhibiting similarities to and differences from freshly purified 1° cells. Across each cell type, we found an inverse relationship between proliferative and maturation states, with preculture 1° AEC2s being most quiescent/mature and iAEC2s being most proliferative/least mature. Cultures of either type of human AEC2s did not generate detectable alveolar type 1 cells in these defined conditions; however, a subset of iAEC2s cocultured with fibroblasts acquired a transitional cell state described in mice and humans to arise during fibrosis or following injury. Hence, we provide direct comparisons of the transcriptomic programs of 1° and engineered AEC2s, 2 in vitro models that can be harnessed to study human lung health and disease.

Identifiants

pubmed: 36454643
pii: 158937
doi: 10.1172/jci.insight.158937
pmc: PMC9870086
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : R35 HL150876
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL132266
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL152970
Pays : United States
Organisme : NCATS NIH HHS
ID : U01 TR001810
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES013508
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL125821
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL148692
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL108793
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL134766
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095993
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001430
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL134745
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL145408
Pays : United States

Références

Cell Stem Cell. 2020 Dec 3;27(6):962-973.e7
pubmed: 32979316
Am J Respir Cell Mol Biol. 1993 Jul;9(1):64-72
pubmed: 8338678
JCI Insight. 2022 Mar 22;7(6):
pubmed: 35315362
Biochim Biophys Acta. 1988 Nov 18;972(2):152-66
pubmed: 2847805
Free Radic Biol Med. 2006 Jun 1;40(11):1914-28
pubmed: 16716893
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4362-4371
pubmed: 30782824
Cell Stem Cell. 2020 Dec 3;27(6):905-919.e10
pubmed: 33142113
Nature. 2020 Nov;587(7835):619-625
pubmed: 33208946
Am J Respir Cell Mol Biol. 2017 Mar;56(3):310-321
pubmed: 27749084
Elife. 2020 Nov 09;9:
pubmed: 33164753
Stem Cells. 2012 Sep;30(9):1948-60
pubmed: 22696116
JCI Insight. 2019 Mar 26;5:
pubmed: 30913038
Am J Respir Cell Mol Biol. 2007 Jun;36(6):661-8
pubmed: 17255555
Cell Stem Cell. 2017 Oct 5;21(4):472-488.e10
pubmed: 28965766
Thorax. 2017 May;72(5):481-484
pubmed: 28070014
Biochim Biophys Acta. 1985 Jul 30;846(1):155-66
pubmed: 3839418
Am J Physiol. 1998 Jul;275(1):L155-64
pubmed: 9688947
Am J Pathol. 2022 Mar;192(3):454-467
pubmed: 34973949
Am J Physiol Lung Cell Mol Physiol. 2005 Jan;288(1):L179-89
pubmed: 15447939
Cell Stem Cell. 2020 Sep 3;27(3):366-382.e7
pubmed: 32750316
Am J Med Sci. 2019 May;357(5):374-378
pubmed: 31010463
J Histochem Cytochem. 2010 Oct;58(10):891-901
pubmed: 20566753
Cell Rep. 2021 Aug 31;36(9):109636
pubmed: 34469722
Nat Commun. 2020 Jul 16;11(1):3559
pubmed: 32678092
Nat Commun. 2022 Nov 21;13(1):7137
pubmed: 36414616
Cell Stem Cell. 2021 Oct 7;28(10):1775-1789.e5
pubmed: 33974915
Cell Stem Cell. 2020 Dec 3;27(6):890-904.e8
pubmed: 33128895
Am J Respir Cell Mol Biol. 1998 Feb;18(2):168-78
pubmed: 9476903
Am J Physiol Cell Physiol. 2014 Jun 1;306(11):C987-96
pubmed: 24740535
Am J Physiol. 1995 Sep;269(3 Pt 1):L344-50
pubmed: 7573468
Am J Respir Cell Mol Biol. 1990 Jul;3(1):33-43
pubmed: 2363935
Trends Mol Med. 2021 Dec;27(12):1159-1174
pubmed: 34674972
Am J Respir Cell Mol Biol. 2021 Oct;65(4):442-460
pubmed: 34101541
Cell. 2020 Jan 9;180(1):107-121.e17
pubmed: 31866069
Am J Respir Crit Care Med. 2014 May 15;189(10):1161-72
pubmed: 24641682
Development. 2017 Nov 1;144(21):3879-3893
pubmed: 28947536
Cell. 2014 Jan 30;156(3):440-55
pubmed: 24485453
Sci Adv. 2020 Jul 08;6(28):eaba1972
pubmed: 32832598
Nat Biotechnol. 2020 Jun;38(6):747-755
pubmed: 32518403
Science. 2021 Mar 12;371(6534):
pubmed: 33707239
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):E1475-83
pubmed: 22123957
Nat Commun. 2015 Apr 13;6:6727
pubmed: 25865356
Nat Methods. 2017 Nov;14(11):1097-1106
pubmed: 28967890
Am J Physiol Lung Cell Mol Physiol. 2002 Nov;283(5):L940-51
pubmed: 12376347
Am J Physiol. 1992 Jun;262(6 Pt 1):L773-8
pubmed: 1616060
Circ Res. 2018 Aug 17;123(5):512-514
pubmed: 30355143
Nature. 2018 Mar 8;555(7695):251-255
pubmed: 29489752
Am J Physiol. 1989 Aug;257(2 Pt 1):L137-43
pubmed: 2475036
Cell Rep. 2021 May 4;35(5):109055
pubmed: 33905739
Nat Cell Biol. 2020 Aug;22(8):934-946
pubmed: 32661339
Nat Protoc. 2019 Dec;14(12):3303-3332
pubmed: 31732721
Am J Physiol. 1992 Apr;262(4 Pt 1):L427-36
pubmed: 1566858
Am J Physiol Lung Cell Mol Physiol. 2020 Jul 1;319(1):L173-L184
pubmed: 32432919
Am J Respir Cell Mol Biol. 1990 Feb;2(2):183-92
pubmed: 2306374
Nat Cell Biol. 2022 Jan;24(1):10-23
pubmed: 34969962
Sci Adv. 2019 Dec 04;5(12):eaaw3851
pubmed: 31840053
Sci Adv. 2020 Jul 08;6(28):eaba1983
pubmed: 32832599
Am J Respir Cell Mol Biol. 1995 May;12(5):497-502
pubmed: 7742013
Brief Bioinform. 2019 Nov 27;20(6):2316-2326
pubmed: 30137247
Development. 2013 Aug;140(15):3285-96
pubmed: 23861064
Biochim Biophys Acta. 1988 Jun 30;970(2):146-56
pubmed: 3382696
Stem Cells. 2021 Feb;39(2):156-169
pubmed: 33241896
Am J Respir Cell Mol Biol. 2022 Dec;67(6):623-631
pubmed: 36036918
Cell Stem Cell. 2020 Apr 2;26(4):593-608.e8
pubmed: 32004478
Hum Pathol. 1985 Oct;16(10):1015-24
pubmed: 4043950
Nature. 2020 Dec;588(7839):670-675
pubmed: 33238290
J Clin Invest. 2013 Jul;123(7):3025-36
pubmed: 23921127
J Biol Chem. 2022 Aug;298(8):102219
pubmed: 35780830
Am J Respir Cell Mol Biol. 2006 Feb;34(2):158-66
pubmed: 16239643
PLoS One. 2014 Apr 01;9(4):e93413
pubmed: 24690998
Cell Rep. 2016 Nov 22;17(9):2312-2325
pubmed: 27880906
J Clin Invest. 2017 Jun 1;127(6):2277-2294
pubmed: 28463226
Cell Rep. 2021 May 11;35(6):109092
pubmed: 33979629
JCI Insight. 2016 Dec 8;1(20):e90558
pubmed: 27942595
Science. 2018 Mar 9;359(6380):1118-1123
pubmed: 29420258

Auteurs

Konstantinos-Dionysios Alysandratos (KD)

Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts, USA.
The Pulmonary Center and Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.

Carolina Garcia-de-Alba (C)

Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.

Changfu Yao (C)

Women's Guild Lung Institute.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, and.
Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Patrizia Pessina (P)

Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, Texas, USA.

Jessie Huang (J)

Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts, USA.
The Pulmonary Center and Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.

Carlos Villacorta-Martin (C)

Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts, USA.
The Pulmonary Center and Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.

Olivia T Hix (OT)

Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts, USA.

Kasey Minakin (K)

Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts, USA.

Claire L Burgess (CL)

Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts, USA.
The Pulmonary Center and Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.

Pushpinder Bawa (P)

Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts, USA.

Aditi Murthy (A)

Pulmonary, Allergy, and Critical Care Division, Department of Medicine, and.
PENN-CHOP Lung Biology Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Bindu Konda (B)

Women's Guild Lung Institute.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, and.
Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Michael F Beers (MF)

Pulmonary, Allergy, and Critical Care Division, Department of Medicine, and.
PENN-CHOP Lung Biology Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Barry R Stripp (BR)

Women's Guild Lung Institute.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, and.
Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Carla F Kim (CF)

Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.

Darrell N Kotton (DN)

Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts, USA.
The Pulmonary Center and Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH